Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening

Janus kinase 2 (JAK2) plays a crucial role in the pathomechanism of myeloproliferative disorders and hematologic malignancies. A somatic mutation of JAK2 (Val617Phe) was previously shown to occur in 98% of patients with polycythemia vera and 50% of patients with essential thrombocythemia and primary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kiss, Róbert, Polgár, Tímea, Kirabo, Annet, Sayyah, Jacqueline, Figueroa, Nicholas C., List, Alan F., Sokol, Lubomir, Zuckerman, Kenneth S., Gali, Meghanath, Bisht, Kirpal S., Sayeski, Peter P., Keserű, György M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2812898/
https://ncbi.nlm.nih.gov/pubmed/19447617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2009.04.138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados